The da Vinci surgical system is currently the only US Food and Drug Administration (FDA) approved robotic system used for ...

The global Structural Heart Devices market is expected to grow to USD 25.69 Billion by 2029, up from USD 16.31 Billion in ...

We describe the example of a hypothetical patient registry for valvular heart disease, a condition for which there is substantial variation ... with functional improvement and complications after ...

A Scottsdale hospital became the first non-clinical trial site in Arizona to perform a tricuspid heart valve replacement.